| scholarly article | Q13442814 |
| P50 | author | Andreas E. Albers | Q56953041 |
| Robert L Ferris | Q38328358 | ||
| P2093 | author name string | Xu Qian | |
| Andreas M Kaufmann | |||
| Thomas K Hoffmann | |||
| Albert B DeLeo | |||
| Daphne Mytilineos | |||
| P2860 | cites work | Frequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer. | Q52012168 |
| ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status. | Q52884612 | ||
| [Prophylactic and therapeutic vaccines against human papilloma virus]. | Q52903256 | ||
| Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck. | Q53625790 | ||
| Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites | Q56902548 | ||
| The Ability of Variant Peptides to Reverse the Nonresponsiveness of T Lymphocytes to the Wild-Type Sequence p53264-272 Epitope | Q57209306 | ||
| Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance | Q74597422 | ||
| Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma | Q77670022 | ||
| Functional subsets of memory T cells identified by CCR7 expression | Q28141547 | ||
| The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
| Central memory and effector memory T cell subsets: function, generation, and maintenance | Q29615097 | ||
| Phase I dendritic cell p53 peptide vaccine for head and neck cancer | Q30577847 | ||
| Signaling defects in T lymphocytes of patients with malignancy | Q33740933 | ||
| Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer | Q34477841 | ||
| CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis | Q35674757 | ||
| Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer | Q36616391 | ||
| Lack of MHC class I surface expression on neoplastic cells and poor activation of the secretory pathway of cytotoxic cells in oral squamous cell carcinomas | Q36640998 | ||
| Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancer | Q37040545 | ||
| Biology and immunology of cancer stem(-like) cells in head and neck cancer | Q38439697 | ||
| Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck. | Q40344942 | ||
| Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. | Q40448724 | ||
| Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck. | Q40500501 | ||
| Generation of T cells specific for the wild-type sequence p53(264-272) peptide in cancer patients: implications for immunoselection of epitope loss variants | Q40739857 | ||
| The use of HLA A2.1/p53 peptide tetramers to visualize the impact of self tolerance on the TCR repertoire | Q40908102 | ||
| Generation of anti-p53 cytotoxic T lymphocytes from human peripheral blood using autologous dendritic cells | Q40944863 | ||
| Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck | Q43164702 | ||
| Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma | Q45019691 | ||
| PD-1 Status in CD8+ T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer. | Q47806987 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | head and neck cancer | Q1783924 |
| head and neck carcinoma | Q18554836 | ||
| neck cancer | Q18966654 | ||
| P304 | page(s) | 10716 | |
| P577 | publication date | 2018-07-16 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Phenotype of p53 wild-type epitope-specific T cells in the circulation of patients with head and neck cancer | |
| P478 | volume | 8 |
| Q90350381 | A Potent Tumor-Reactive p53-Specific Single-Chain TCR without On- or Off-Target Autoimmunity In Vivo | cites work | P2860 |
Search more.